Emerging Therapeutic Strategies Targeting Muscle Wasting in Parkinson’s Disease: From Sarcopenia to Cachexia-like Syndrome
Biomolecules · 17.11.2026 · 16 (11) · 1669
DOI: 10.3390/biom16111669 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomolecules, online erschienen am 17.11.2026. Verfasst von Emilia Manole und 4 weiteren Autor:innen. Die Arbeit nennt 135 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Romanian Ministry of Research, Innovation and Digitization.
Abstract (Originalsprache)
Clinically relevant muscle wasting affects a substantial proportion of patients with Parkinson’s disease (PD), although its prevalence varies according to the diagnostic criteria applied. This condition accelerates disease progression, reduces quality of life, and is a poor prognostic indicator associated with increased disability and mortality. Despite its clinical relevance, the molecular mechanisms underlying muscle wasting remain underinvestigated and poorly understood, constituting an unmet clinical need. Currently, there is insufficient evidence to definitively establish PD-associated muscle wasting as true cachexia, a syndrome characterized by systemic inflammation and metabolic dysregulation. Moreover, distinguishing the contribution of age-related sarcopenia from PD-specific pathological mechanisms remains challenging. A deeper understanding of the pathways and molecular signals involved in PD-associated muscle wasting may lead to therapeutic strategies to improve patient outcomes. Given the multifactorial nature of PD muscle wasting—e.g., motor neuron degeneration, aging, oxidative stress, inflammation, protein degradation, mitochondrial dysfunction—our aim is to provide a comprehensive overview of the current data on the cellular, molecular, and systemic mechanisms involved in this process. We also identify emerging therapeutic targets that may help prevent, attenuate, or reverse muscle atrophy in PD. Understanding muscle–brain crosstalk may redefine PD as a systemic rather than neurodegenerative disorder.
Förderung
- Romanian Ministry of Research, Innovation and Digitization
Zitieren
APA
Manole, E., Gaina, G., Dragnea, E. M., Ceafalan, L. C., & Popescu, B. O. (2026). Emerging Therapeutic Strategies Targeting Muscle Wasting in Parkinson’s Disease: From Sarcopenia to Cachexia-like Syndrome. Biomolecules, 16(11), 1669. https://doi.org/10.3390/biom16111669
Vancouver
Manole E, Gaina G, Dragnea EM, Ceafalan LC, Popescu BO. Emerging Therapeutic Strategies Targeting Muscle Wasting in Parkinson’s Disease: From Sarcopenia to Cachexia-like Syndrome. Biomolecules. 2026;16(11):1669. doi:10.3390/biom16111669
BibTeX
@article{Manole2026,
author = {Manole, Emilia and Gaina, Gisela and Dragnea, Elena Mihaela and Ceafalan, Laura Cristina and Popescu, Bogdan Ovidiu},
title = {Emerging Therapeutic Strategies Targeting Muscle Wasting in Parkinson’s Disease: From Sarcopenia to Cachexia-like Syndrome},
journal = {Biomolecules},
year = {2026},
volume = {16},
number = {11},
pages = {1669},
doi = {10.3390/biom16111669}
}
EUVIMED